ACLX - Arcellx, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
86.95 5.46 (6.28%) --- --- --- --- 5.46 (6.28%) --- ---

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.94
Diluted EPS:
-0.94
Basic P/E:
-98.3085
Diluted P/E:
-98.3085
RSI(14) 1m:
86.47
VWAP:
92.37
RVol:
0.8052

Events

Period Kind Movement Occurred At
1m Price increase 1m 88.98 +1.25 (+1.42%) Oct 15 09:48
1m Price decrease 1m 88.05 -0.93 (-1.05%) Oct 15 09:42

Related News